Posted on June 18, 2009 by Patients and Patents
A landmark collaboration could see the development of the first new-action tuberculosis drug in 40 years. Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec, a Johnson & Johnson company, have joined forces to focus on the development of the new experimental drug TMC207.
Forbes reports that if the drug [...]
Filed under: Innovation, Public health | Tagged: drug development, Innovation, tuberculosis, World Health Organization | Leave a Comment »
Posted on June 17, 2009 by Michael McDonough
A recent article by the San Diego Union-Tribune raises concerns over online pharmacies. According to the piece, a vast majority of online pharmacies may not be compliant with US Federal standards. Carmen Catizone, executive director of the National Association of Boards of Pharmacy (NABP), was quoted as saying, “We have found that 92 percent of [...]
Filed under: Counterfeit drugs | Tagged: Counterfeit drugs, internet pharmacies, patient safety | Leave a Comment »
Posted on June 11, 2009 by Patients and Patents
The BBC reports that UN health officials are expected to declare the first global flu pandemic in 40 years, after holding emergency talks on the swine flu crisis.
WHO poised to declare first flu pandemic in 40 years
Flu experts expected to recommend move to phase 6
Expected to urge finishing seasonal flu vaccine production
Spread of virus in [...]
Filed under: Public health | Tagged: H1N1, Public health, Swine flu | Leave a Comment »
Posted on June 8, 2009 by Patients and Patents
Bloomberg reported that Economic ministers from Japan and China will start a working group on protecting intellectual property rights as part of an effort to tighten economic ties during the global recession.
Asia’s two largest economies agreed to set up a working group to discuss intellectual property, implement economic measures pledged at the Group of 20 [...]
Filed under: Asia, intellectual property | Tagged: China, intellectual property | Leave a Comment »
Posted on June 5, 2009 by Patients and Patents
Many health experts are concerned that the growing resistance to artemisinin drugs in western Cambodia could result in a repeat of the fate of chloroquine, which became largely ineffective. Counterfeit drugs can contain insufficient amounts of active ingredient, failing to cure the disease parasite and allowing it to mutate and resist the drug. With half [...]
Filed under: Asia, Counterfeit drugs | Tagged: counterfeit medicines, malaria, Counterfeit drugs, drug pricing, Public health | Leave a Comment »
GAVI announces innovative approach to developing vaccines for developing nations
At the end of last week, the GAVI Alliance partners (the World Bank, WHO and UNICEF), five national governments and the Bill & Melinda Gates Foundation formally announced the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.
The Wall Street Journal reports that the $1.5 billion program marks a departure [...]
Filed under: Commentary on news & events, Innovation, Public health | Tagged: access to medicines, Bill & Melinda Gates Foundation, GAVI Alliance, Innovation, vaccine, World Health Organization | Leave a Comment »